News|Articles|May 14, 2026

Health Care Managers Play a Critical Role in Hepatitis B Vaccination Programs for Health Care Workers

Fact checked by: Ron Panarotti
Listen
0:00 / 0:00

Key Takeaways

  • Global hepatitis B virus (HBV)/hepatitis C virus mortality (approximately 1.34 million deaths in 2024) and daily incident infections underscore that 2030 elimination targets require stronger institutional worker protection strategies.
  • Developing country data attribute 40% to 65% of health care worker HBV infections to occupational percutaneous exposure, making series completion and documented immunity operationally nonnegotiable.
SHOW MORE

HBV still threatens health workers as vaccination programs stall; learn how managers and pharmacists can boost coverage with digital tracking.

Health care workers (HCWs) face an elevated occupational risk of acquiring bloodborne infections, and hepatitis B virus (HBV) remains one of the most serious. A 2026 perspective study published in the Indian Journal of Community Medicine examined how health care managers at a tertiary institution operationalize HBV vaccination programs for their workforce, shedding light on a gap in occupational health infrastructure that pharmacists and pharmacy leaders are well positioned to help close.1

The Burden of HBV Among HCWs

The global toll of HBV infection underscores the urgency of protecting frontline workers. According to the World Health Organization (WHO) 2026 Global Hepatitis Report, HBV and hepatitis C virus together claimed about 1.34 million lives in 2024, with more than 4900 new infections occurring daily. The WHO's elimination strategy calls for approximately a 90% reduction in new infections and a 65% reduction in mortality by 2030, targets that remain out of reach without accelerated action.2

HCWs are among the most vulnerable populations. In developing countries, an estimated 40% to 65% of HBV infections among HCWs have been attributed to percutaneous occupational exposure, such as needle-stick injuries. Despite the availability of a highly effective vaccine, one that confers approximately 96% protection against HBV infection, complete vaccination coverage among HCWs remains alarmingly inconsistent.2

A Multilevel Management Challenge

The 2026 perspective study offers a practical framework for understanding where HBV vaccination programs succeed and where they break down. The study authors outline distinct challenges at 3 managerial levels within a tertiary care institution.1

For executive directors, medical superintendents, and central pharmacies, the primary obstacles are prolonged approval timelines, budget constraints, and the competing demand of integrating HBV vaccination delivery alongside the Universal Immunization Program. Nodal officers and nursing superintendents struggle to maintain accurate, up-to-date vaccination records amid frequent staff turnover, and coordination gaps between departments delay the reporting of new employees' vaccination status. Nursing officers and residents on the ground face the practical challenge of following up with HCWs who miss their scheduled vaccine doses, which is a failure that can lead to unpredictable surges in demand and disrupted logistics chains.1

The study authors recommend biannual awareness campaigns to improve uptake among newly onboarded staff, as well as a transition to digital vaccination records to create a centralized repository and support future planning.1

Where Pharmacy Fits In

The central pharmacy is explicitly identified in this study as a top-level manager in HBV vaccination programs, responsible for vaccine supply chain oversight and procurement decisions. This places pharmacists within the operational infrastructure of HCW vaccination, not merely as dispensers, but as institutional decision makers whose actions upstream directly affect frontline coverage.1

The Advisory Committee on Immunization Practices and the CDC both recommend that all HCWs with anticipated exposure risk complete the full HBV series and have their immunity documented. For pharmacy leaders, this recommendation carries an institutional obligation, which includes ensuring vaccine availability, supporting documentation systems, and flagging coverage gaps before they become a liability.3

Needle-stick and sharp-related injuries are among the most common mechanisms of HBV transmission in clinical settings. A cross-sectional study of HCWs found that percutaneous exposure accounted for more than 75% of occupational exposure incidents, with blood as the most frequently involved material, reinforcing that vaccination completion, not just initiation, is critical for protection.4

Closing the Coverage Gap

The study authors concluded that coordinated managerial effort across all institutional levels is essential to achieving complete HBV vaccination coverage among HCWs. For pharmacists, this is an operational and an advocacy imperative. Improving baseline data collection on vaccination status, streamlining interdepartmental communication, and supporting digital immunization records are practical steps pharmacy departments can champion.1

As the 2030 hepatitis elimination deadline draws closer and the WHO warns that current progress is insufficient to meet global targets, health care institutions must treat HCW vaccination not as an administrative afterthought but as a frontline public health priority, one that pharmacy is uniquely equipped to advance.2

REFERENCES

1. Bali S, Gouroumourty R. Health care managers' role and challenges in implementing hepatitis B vaccination for health care workers in a tertiary setting. Indian J Community Med. 2026;51(2):238-241. doi:10.4103/ijcm.ijcm_591_24
2. Efforts to eliminate hepatitis deliver gains but more action needed to meet 2030 targets. News release. World Health Organization. April 28, 2026. Accessed May 14, 2026. https://www.who.int/news/item/28-04-2026-efforts-to-eliminate-hepatitis-delivers-gains-but-more-action-needed-to-meet-2030-targets
3. Viral hepatitis exposure risk among health care providers. CDC. May 14, 2024. Accessed May 14, 2026. https://www.cdc.gov/hepatitis/hcp/populations-settings/health-care-providers.html
4. Frison FS, Alonzo HGA, Guerreiro IC, de Oliveira ECP. Hepatitis B vaccination coverage and serological status among health care workers exposed to occupational biological hazards. Rev Bras Med Trab. 2023;21(3):e2022963. doi:10.47626/1679-4435-2022-963

Latest CME